Attention AACR Annual Meeting 2018 Registrants – Activate Your Access

Login for full access:

Username and password are not your MyAACR account information

Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Conferences:

Availability:

Participation Type:

Presentations Access:

Presentation Access:

Topic Tracks*:

Organ Site Tracks*:

  • Sort by:
  • Browse by:
<< first | < prev page: of 4 records per page: next > | last >>
pages: 1 2 3 4 presentations: 1 to 25 of 98
Biosimilar biologic products: The US FDA perspective
Joseph Franklin
U.S. Food and Drug Administration, Silver Spring, MD, United States
from AACR Annual Meeting 2018 on April 14, 2018 1:00 PM-3:00 PM
Biologic complexity: Implications for biosimilar development
Simon Hotchin
Amgen, Inc., Thousand Oaks, CA, United States
from AACR Annual Meeting 2018 on April 14, 2018 1:00 PM-3:00 PM
Biosimilar development: Clinical implications and applications
Sara A Hurvitz
UCLA, Santa Monica, CA, United States
from AACR Annual Meeting 2018 on April 14, 2018 1:00 PM-3:00 PM
Biosimilar regulatory policy: Understanding the landscape and relevance to medical practice
Sue Lim
U.S. Food and Drug Administration, Silver Spring, MD, United States
from AACR Annual Meeting 2018 on April 14, 2018 1:00 PM-3:00 PM
Invited Speaker
Amy L. Rubinstein
National Institutes of Health, Bethesda, MD, United States
from AACR Annual Meeting 2018 on April 15, 2018 7:00 AM-8:00 AM
Invited Speaker
Daniel L. Gallahan
National Cancer Institute, Bethesda, MD, United States
from AACR Annual Meeting 2018 on April 15, 2018 7:00 AM-8:00 AM
Chairperson
George D Demetri
Dana-Farber Cancer Inst., Boston, MA, United States
from AACR Annual Meeting 2018 on April 15, 2018 3:00 PM-4:30 PM
Panelist
Kristin Anderson
Fred Hutchinson Cancer Research Ctr., Seattle, WA, United States
from AACR Annual Meeting 2018 on April 15, 2018 3:00 PM-4:30 PM
Panelist
Beth Anne Baber
The Nicholas Conor Institute, San Diego, CA, United States
from AACR Annual Meeting 2018 on April 15, 2018 3:00 PM-4:30 PM
Panelist
M.K. Holohan Quattrocchi
National Cancer Institute, Bethesda, MD, United States
from AACR Annual Meeting 2018 on April 15, 2018 3:00 PM-4:30 PM
Panelist
Mary Lee Watts
AACR, Washington, DC, United States
from AACR Annual Meeting 2018 on April 15, 2018 3:00 PM-4:30 PM
Invited Speaker
David R Spigel
Sarah Cannon Research Inst., Nashville, TN, United States
from AACR Annual Meeting 2018 on April 16, 2018 7:00 AM-8:00 AM
Chairperson
Roy S Herbst
Yale Cancer Ctr., New Haven, CT, United States
from AACR Annual Meeting 2018 on April 16, 2018 1:00 PM-2:45 PM
Panelist
Brian A. King
Centers for Disease Control and Prevention, Atlanta, GA, United States
from AACR Annual Meeting 2018 on April 16, 2018 1:00 PM-2:45 PM
Panelist
Michele Bloch
National Cancer Institute, Rockville, MD, United States
from AACR Annual Meeting 2018 on April 16, 2018 1:00 PM-2:45 PM
Panelist
Dorothy K Hatsukami
Univ. of Minnesota, Minneapolis, MN, United States
from AACR Annual Meeting 2018 on April 16, 2018 1:00 PM-2:45 PM
Panelist
Christopher S Lathan
Dana-Farber Cancer Inst., Boston, MA, United States
from AACR Annual Meeting 2018 on April 16, 2018 1:00 PM-2:45 PM
Panelist
Cathy L. Backinger
Food and Drug Administration, Rockville, MD, United States
from AACR Annual Meeting 2018 on April 16, 2018 1:00 PM-2:45 PM
Government and civil society efforts in global cancer control
Ophira Ginsburg
NYU Langone Health, New York, NY, United States
from AACR Annual Meeting 2018 on April 17, 2018 1:00 PM-2:45 PM
Innovative strategies for overcoming global disparities in cancer risk assessment and prevention
Olufunmilayo I Olopade
Univ. of Chicago Medical Ctr., Chicago, IL, United States
from AACR Annual Meeting 2018 on April 17, 2018 1:00 PM-2:45 PM
Opportunities for international partnering in cancer diagnosis and treatment
Julie R Gralow
Univ. of Washington School of Med., Seattle, WA, United States
from AACR Annual Meeting 2018 on April 17, 2018 1:00 PM-2:45 PM
Biden Cancer Initiative Colloquium
Gregory Simon
Biden Cancer Initiative, Washington, DC, United States
Elizabeth M Jaffee
Johns Hopkins Sidney Kimmel Comp. Cancer Ctr., Baltimore, MD, United States
Stanton L Gerson
Case Comprehensive Cancer Ctr., Cleveland, OH, United States
Jay Holley
Uber Health, San Francisco, CA, United States
Carla Tardif
Family Reach, Boston, MA, United States
Asif Dhar
Deloitte, New York, NY, United States
Louis J DeGennaro
The Leukemia & Lymphoma Society, White Plains, NY, United States
Patricia Doykos
Bristol-Myers Squibb Foundation, New York, NY, United States
Carol Brown
Memorial Sloan Kettering Cancer Center, New York, NY, United States
from AACR Annual Meeting 2018 on April 17, 2018 5:00 PM-6:30 PM
Disparities in the use of targeted therapies for breast cancer
Katherine Reeder-Hayes
University Of North Carolina At Chapel Hil, Chapel Hill, NC, United States
from AACR Annual Meeting 2018 on April 18, 2018 10:15 AM-12:00 PM
Crossing the Divide: Disparities in access to personalized medicine for lung cancer
Christopher S Lathan
Dana-Farber Cancer Inst., Boston, MA, United States
from AACR Annual Meeting 2018 on April 18, 2018 10:15 AM-12:00 PM
Toward a more sustainable path for targeted cancer drugs
Justin Bekelman
Abramson Cancer Ctr. of Univ. of Penn., Philadelphia, PA, United States
from AACR Annual Meeting 2018 on April 18, 2018 10:15 AM-12:00 PM
<< first | < prev page: of 4 records per page: next > | last >>
pages: 1 2 3 4 presentations: 1 to 25 of 98